Investing Profile

Diyong Xu

InvestorVC
Principal at Orbimed
orbimed.comNew York, New York
Photo of Diyong Xu, Principal at OrbiMed
cb
OrbiMed Principal
$1M - $75.0M
$4.0M
4
$18B
CompanyStageDateRound SizeTotal Raised
Q32 Bio
Post Ipo EquityMar 2024$42M
Series BOct 2020$60M
Series AMay 2020$46M
$150M
Co-investors: Isaac Manke (Acorn Bioventures), David Grayzel (Atlas Venture)
OnCusp Therapeutics
Series AJan 2024$100M
$100M
Co-investors: Chong Xu (F-Prime Capital Partners), Karen Hong (Novo Ventures)